SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Hedlin G.) "

Sökning: WFRF:(Hedlin G.)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Papadopoulos, N G, et al. (författare)
  • International consensus on (ICON) pediatric asthma.
  • 2012
  • Ingår i: Allergy. - 1398-9995. ; 67:8, s. 976-97
  • Tidskriftsartikel (refereegranskat)abstract
    • Asthma is the most common chronic lower respiratory disease in childhood throughout the world. Several guidelines and/or consensus documents are available to support medical decisions on pediatric asthma. Although there is no doubt that the use of common systematic approaches for management can considerably improve outcomes, dissemination and implementation of these are still major challenges. Consequently, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), recently formed by the EAACI, AAAAI, ACAAI, and WAO, has decided to propose an International Consensus on (ICON) Pediatric Asthma. The purpose of this document is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on any differences, thus providing a concise reference. The principles of pediatric asthma management are generally accepted. Overall, the treatment goal is disease control. To achieve this, patients and their parents should be educated to optimally manage the disease, in collaboration with healthcare professionals. Identification and avoidance of triggers is also of significant importance. Assessment and monitoring should be performed regularly to re-evaluate and fine-tune treatment. Pharmacotherapy is the cornerstone of treatment. The optimal use of medication can, in most cases, help patients control symptoms and reduce the risk for future morbidity. The management of exacerbations is a major consideration, independent of chronic treatment. There is a trend toward considering phenotype-specific treatment choices; however, this goal has not yet been achieved.
  •  
3.
  • Östling, Jörgen, et al. (författare)
  • IL-17-high asthma with features of a psoriasis immunophenotype
  • 2019
  • Ingår i: Journal of Allergy and Clinical Immunology. - Elsevier. - 0091-6749 .- 1097-6825. ; 144:5, s. 1198-1213
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: The role of IL-17 immunity is well established in patients with inflammatory diseases, such as psoriasis and inflammatory bowel disease, but not in asthmatic patients, in whom further study is required.Objective: We sought to undertake a deep phenotyping study of asthmatic patients with upregulated IL-17 immunity.Methods: Whole-genome transcriptomic analysis was performed by using epithelial brushings, bronchial biopsy specimens (91 asthmatic patients and 46 healthy control subjects), and whole blood samples (n = 498) from the Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes (U-BIOPRED) cohort. Gene signatures induced in vitro by IL-17 and IL-13 in bronchial epithelial cells were used to identify patients with IL-17–high and IL-13–high asthma phenotypes.Results: Twenty-two of 91 patients were identified with IL-17, and 9 patients were identified with IL-13 gene signatures. The patients with IL-17–high asthma were characterized by risk of frequent exacerbations, airway (sputum and mucosal) neutrophilia, decreased lung microbiota diversity, and urinary biomarker evidence of activation of the thromboxane B2 pathway. In pathway analysis the differentially expressed genes in patients with IL-17-high asthma were shared with those reported as altered in psoriasis lesions and included genes regulating epithelial barrier function and defense mechanisms, such as IL1B, IL6, IL8, and β-defensin.Conclusion: The IL-17–high asthma phenotype, characterized by bronchial epithelial dysfunction and upregulated antimicrobial and inflammatory response, resembles the immunophenotype of psoriasis, including activation of the thromboxane B2 pathway, which should be considered a biomarker for this phenotype in further studies, including clinical trials targeting IL-17.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (1)
Typ av publikation
tidskriftsartikel (154)
konferensbidrag (16)
bokkapitel (4)
bok (1)
recension (1)
Typ av innehåll
refereegranskat (132)
övrigt vetenskapligt (43)
populärvet., debatt m.m. (2)
Författare/redaktör
Hedlin, G (171)
van Hage, M, (20)
Wickman, M (20)
Lilja, G, (17)
Bush, A. (15)
Pershagen, G (14)
visa fler...
Melen, E (13)
Soderhall, C, (12)
Dahlen, SE, (11)
Wennergren, Göran, 1 ... (11)
Asarnoj, A, (11)
Carlsen, KH (11)
Kull, I (10)
Gronlund, H, (9)
Roberts, G (9)
Ostblom, E, (9)
Dahlen, B, (8)
Lonnkvist, K (8)
Carlsen, KCL (8)
Bisgaard, H (8)
James, A. (7)
Kere, J (7)
Nilsson, C, (7)
Svartengren, M. (7)
Almqvist, C, (7)
Hashimoto, S. (7)
Valenta, R (6)
Foucard, T (6)
van Hage-Hamsten, M, (6)
Nordvall, L, (6)
Hallden, G (6)
Bonnelykke, K. (6)
Chanez, P (5)
Djukanovic, R (5)
Vestbo, J (5)
Chung, KF (5)
Sterk, PJ (5)
Ahlstedt, S, (5)
Alving, K (5)
Wahn, U. (5)
Lundahl, J, (5)
Janson, Staffan, (5)
Nilsson, N (5)
Sousa, AR (5)
Horvath, I. (5)
Sandstrom, T (5)
Skjerven, HO (5)
BORRES, MP (5)
Hederos, C-A (5)
Hederos, CA (5)
visa färre...
Lärosäte
Karolinska Institutet (146)
Uppsala universitet (21)
Göteborgs universitet (16)
Karlstads universitet (7)
Umeå universitet (5)
Kungliga Tekniska Högskolan (3)
visa fler...
Lunds universitet (2)
Stockholms universitet (1)
Örebro universitet (1)
RISE (1)
Röda Korsets Högskola (1)
visa färre...
Språk
Engelska (168)
Svenska (7)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (37)
Naturvetenskap (3)
Samhällsvetenskap (2)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy